Rakuten Securities’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71 Hold
2
﹤0.01% 882
2026
Q1
$55 Sell
2
-870
-100% -$22.4K ﹤0.01% 858
2025
Q4
$18.9K Buy
872
+870
+43,500% +$17.2K 0.01% 342
2025
Q3
$30 Hold
2
﹤0.01% 901
2025
Q2
$23 Sell
2
-299
-99% -$3.24K ﹤0.01% 838
2025
Q1
$3.04K Buy
301
+300
+30,000% +$3.24K ﹤0.01% 551
2024
Q4
$12 Buy
+1
New +$12 ﹤0.01% 759
2024
Q3
Sell
-325
Closed -$3.44K 776
2024
Q2
$3.44K Buy
+325
New +$3.56K ﹤0.01% 432

Other funds holding ROIV

Rakuten Securities's ROIV Position: Q2 2026 in Review

Rakuten Securities held its Roivant Sciences (ROIV) position steady in Q2 2026 at 2 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Rakuten Securities first reported a position in ROIV in Q2 2024 and has held it in 8 quarters since. The position peaked at $18.9K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Rakuten Securities held 2 shares of Roivant Sciences worth $71 as of Q2 2026.
  • Rakuten Securities left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #882 holding.
  • Rakuten Securities first reported a position in Roivant Sciences in Q2 2024 and has held it in 8 quarters since.
  • Rakuten Securities's Roivant Sciences position peaked at $18.9K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.